Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(anakinra)
5,356 results
  • Biologics in SAPHO syndrome: A systematic review. [Review]
  • SASemin Arthritis Rheum 2018 Apr 17
  • Daoussis D, Konstantopoulou G, … Liossis SN
  • CONCLUSIONS: In SAPHO patients not responding to conventional treatment, TNF blockers appear to be the first choice. In patients failing TNF blockers, IL-1 inhibitors and biologics targeting the IL-17/IL-23 axis could be used.
  • A Rare but Fascinating Disorder: Case Collection of Patients with Schnitzler Syndrome. [Journal Article]
  • CRCase Rep Rheumatol 2018; 2018:7041576
  • Bashir M, Bettendorf B, Hariman R
  • CONCLUSIONS: Schnitzler syndrome is a rare and underdiagnosed disorder. High suspicion should be maintained in patients with chronic urticaria-like dermatoses, intermittent fevers, and arthralgias. A serum protein electrophoresis and immunofixation should be performed in these patients. The diagnosis is important to recognize as Schnitzler syndrome is associated with malignancy. A lymphoproliferative disorder develops in about 20% of patients at an average of 7.6 years after onset of symptoms. Thus, patients warrant long-term follow-up. IL-1 inhibitors are extremely effective in relieving symptoms and are considered first line therapy.
  • The role of IL-1 in postprandial fatigue. [Journal Article]
  • MMMol Metab 2018 Apr 12
  • Lehrskov LL, Dorph E, … Donath MY
  • CONCLUSIONS: We conclude that IL-1 is involved in the regulation of postprandial fatigue under physiologic conditions in lean and obese individuals. It remains to be shown whether this effect translates into clinical relevant effects.
New Search Next